It covers the computational systems that we built to design and test a new family of chemical compounds in silico, synthesis of several prototypes, all the way through preliminary in vivo testing. It’s the culmination of about 4 yrs of work starting at SENS, finished at Underdog and involving collaborations with leading experts in Spain, Hungary, and China. Give it a look and let us know what you think!
Cyclarity Therapeutics has Moved to the Buck Institute for Research on Aging
Press Release Novato, CA, U.S., June 24, 2022 – Announcing our move to the Buck Institute for Research on Aging. Cyclarity Therapeutics (https://cyclaritytx.com) has just completed the move of its research and operations to the state-of-the-art